# A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).

> **NCT00044226** · PHASE2 · UNKNOWN · sponsor: **Milkhaus Laboratory** · enrollment: 350 (—)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **DRUG:** ML-04A

## Key facts

- **NCT ID:** NCT00044226
- **Lead sponsor:** Milkhaus Laboratory
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-04
- **Primary completion:** —
- **Final completion:** 2002-10
- **Target enrollment:** 350 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00044226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00044226, "A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00044226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*